MOORESTOWN, N.J., Dec. 04, 2017 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (NASDAQ:TRHC) , a healthcare technology optimizing medication safety by deploying new medication risk mitigation digital software solutions and novel, proprietary medication decision support tools, today announced a proposed underwritten public offering of shares of its common stock, which includes 1,350,000 shares offered by TRHC and 1,650,000 shares offered by certain stockholders of TRHC named in the preliminary prospectus supplement. The underwriters have a 30-day option to purchase up to an additional 450,000 shares of common stock from certain of the Selling Stockholders. The offering is subject to market conditions and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.
TRHC intends to use the net proceeds from the offering primarily to repay approximately $35.0 million of outstanding indebtedness under its credit facility. The remaining proceeds will be used for working capital and general corporate purposes. TRHC will not receive any proceeds from shares of common stock to be sold by the Selling Stockholders.
Piper Jaffray & Co. and Citigroup are acting as joint book-running managers for the offering. Baird and William Blair are also acting as bookrunners. Oppenheimer & Co. is acting as lead manager for the offering and First Analysis Securities Corp. is acting as co-manager for the offering. Chardan Capital Markets is acting as a financial advisor for the offering.
About Tabula Rasa HealthCare
Tabula Rasa HealthCare is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs, and manage risk. Medication risk management is TRHC’s lead offering, and its cloud-based software applications provide solutions for a range of payors, providers and other healthcare organizations. For more information, visit: www.TRHC.com.